Adynxx (OTC:ADYX) Stock, Quote.Headers.trade-ideas

Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.

News

Intraday Update

Markets

Movers

Trading Ideas

ACEL

ACTG

ADYX

ALEX

ALSN

AMCX

AMPY

ANGO

ARGO

AROC

ASPS

ATIS

AWSM

BANF

BBVA

BCML

BCOM

BCOR

BERY

BJRI

BOKF

BOMN

BORR

BSBR

BSET

BrightSphere Investment Group plc Ordinary Shares

BSIG

BUSE

CADE

CAKE

CAMP

CATY

CCLP

CDEV

CEQP

CHEF

CHKR

CHMG

CHUY

CLDT

CMLS

CNTY

CPRI

CPTA

CRTO

CVGI

DDMX

DENN

DLTR

DORM

Stocks That Hit 52-Week Lows On Thursday

Adynxx Inc

Adynxx

Comments

Adynxx

Adynxx (OTC:ADYX) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga